Harlan Waksal - Executive Chair, Director at Lyra Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Chair, Director
Issuer Symbol
LYRA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Harlan Waksal since 06 Mar 2025

Holdings reported by Harlan Waksal for Lyra Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 536,966 $1,591,460 $2.96 18 Mar 2024 Direct
Performance-based Restricted Stock Units 0 09 Dec 2024 Direct Common Stock

Transactions reported by Harlan Waksal for Lyra Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.